$3.32
-0.09[-2.64%]
At close: May 17
$3.32
0[0.00%]
After Hours: 4:00PM EDT
Nuvation Bio
(NYSE:NUVB)Nuvation Bio Stock (NYSE:NUVB), Analyst Ratings, Price Targets, Predictions
Nuvation Bio Inc has a consensus price target of $5.79, established from looking at the 20 latest analyst ratings. The last 3 analyst ratings were released from Wedbush, RBC Capital, and HC Wainwright & Co. on May 15, 2024, April 17, 2024, and March 28, 2024. With an average price target of $6 between Wedbush, RBC Capital, and HC Wainwright & Co., there's an implied 80.72% upside for Nuvation Bio Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Wedbush
RBC Capital
HC Wainwright & Co.
Jefferies
BTIG
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Nuvation Bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/15/2024 | Buy Now | 50.6% | Wedbush | David Nierengarten | → $5 | Reiterates | Outperform → Outperform | Get Alert |
| 04/17/2024 | Buy Now | 50.6% | RBC Capital | Kennen MacKay | $4 → $5 | Maintains | Outperform | Get Alert |
| 03/28/2024 | Buy Now | 140.96% | HC Wainwright & Co. | Robert Burns | $5 → $8 | Maintains | Buy | Get Alert |
| 03/27/2024 | Buy Now | 201.2% | Jefferies | Michael Yee | $1.4 → $10 | Upgrade | Hold → Buy | Get Alert |
| 03/26/2024 | Buy Now | 50.6% | BTIG | Kaveri Pohlman | → $5 | Upgrade | Neutral → Buy | Get Alert |
| 03/07/2024 | Buy Now | 50.6% | HC Wainwright & Co. | Robert Burns | $4.5 → $5 | Maintains | Buy | Get Alert |
| 03/01/2024 | Buy Now | 50.6% | Wedbush | David Nierengarten | → $5 | Reiterates | Outperform → Outperform | Get Alert |
| 11/22/2023 | Buy Now | 35.54% | HC Wainwright & Co. | Robert Burns | → $4.5 | Reiterates | Buy → Buy | Get Alert |
| 08/21/2023 | Buy Now | 35.54% | HC Wainwright & Co. | Robert Burns | → $4.5 | Reiterates | Buy → Buy | Get Alert |
| 05/05/2023 | Buy Now | 50.6% | RBC Capital | Gregory Renza | $6 → $5 | Maintains | Outperform | Get Alert |
| 03/24/2023 | Buy Now | 35.54% | HC Wainwright & Co. | Robert Burns | → $4.5 | Reiterates | → Buy | Get Alert |
| 03/16/2023 | Buy Now | 50.6% | Wedbush | David Nierengarten | → $5 | Reiterates | → Outperform | Get Alert |
| 03/16/2023 | Buy Now | 80.72% | RBC Capital | Gregory Renza | → $6 | Reiterates | → Outperform | Get Alert |
| 01/06/2023 | Buy Now | -39.76% | Jefferies | Michael Yee | $5 → $2 | Downgrade | Buy → Hold | Get Alert |
| 08/22/2022 | Buy Now | 35.54% | HC Wainwright & Co. | Robert Burns | $14 → $4.5 | Maintains | Buy | Get Alert |
| 08/02/2022 | Buy Now | -24.7% | BMO Capital | Evan Seigerman | $8 → $2.5 | Downgrade | Outperform → Market Perform | Get Alert |
| 08/02/2022 | Buy Now | — | BTIG | Kaveri Pohlman | — | Downgrade | Buy → Neutral | Get Alert |
| 05/11/2022 | Buy Now | 321.69% | RBC Capital | Gregory Renza | $15 → $14 | Maintains | Outperform | Get Alert |
| 05/04/2022 | Buy Now | 321.69% | HC Wainwright & Co. | Robert Burns | → $14 | Initiates | → Buy | Get Alert |
| 03/22/2022 | Buy Now | 261.45% | BMO Capital | Evan Seigerman | $17 → $12 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Nuvation Bio (NUVB)?
The latest price target for Nuvation Bio (NYSE: NUVB) was reported by Wedbush on May 15, 2024. The analyst firm set a price target for $5.00 expecting NUVB to rise to within 12 months (a possible 50.60% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Nuvation Bio (NUVB)?
The latest analyst rating for Nuvation Bio (NYSE: NUVB) was provided by Wedbush, and Nuvation Bio reiterated their outperform rating.
When was the last upgrade for Nuvation Bio (NUVB)?
The last upgrade for Nuvation Bio Inc happened on March 27, 2024 when Jefferies raised their price target to $10. Jefferies previously had a hold for Nuvation Bio Inc.
When was the last downgrade for Nuvation Bio (NUVB)?
The last downgrade for Nuvation Bio Inc happened on January 6, 2023 when Jefferies changed their price target from $5 to $2 for Nuvation Bio Inc.
When is the next analyst rating going to be posted or updated for Nuvation Bio (NUVB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nuvation Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nuvation Bio was filed on May 15, 2024 so you should expect the next rating to be made available sometime around May 15, 2025.
Is the Analyst Rating Nuvation Bio (NUVB) correct?
While ratings are subjective and will change, the latest Nuvation Bio (NUVB) rating was a reiterated with a price target of $0.00 to $5.00. The current price Nuvation Bio (NUVB) is trading at is $3.32, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.